Interstitial Lung Disease Questionnaire
Questionnaire Study for Patients With Interstitial Lung Disease
2 other identifiers
observational
304
1 country
1
Brief Summary
- 1.To evaluate the health status of patients with Interstitial Lung Disease (ILD), and how this varies between subgroups of ILD.
- 2.To investigate the prevalence of symptoms, anxiety, depression, and sleep-disordered breathing within ILD patient population.
- 3.To assess the economic impact of ILD.
- 4.To understand how self-aware ILD patients are regarding their treatment/management.
- 5.To compare the demographic details, including smoking status and occupational history, of patients with interstitial lung disease
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Nov 2012
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 9, 2012
CompletedFirst Posted
Study publicly available on registry
October 22, 2012
CompletedStudy Start
First participant enrolled
November 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2013
CompletedOctober 22, 2012
October 1, 2012
1 year
October 9, 2012
October 17, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in the Mean K-BILD score between the 4 groups
HRQL
Baseline
Secondary Outcomes (6)
Severity of dyspnoea suffered by patients
Baseline
Prevalence of anxiety and depression
Baseline
Prevalence of sleep-disordered breathing symptoms
Baseline
Degree of self-awareness displayed by patients
Baseline
The costs associated with ILD from a patient and healthcare perspective
Baseline
- +1 more secondary outcomes
Study Arms (4)
Idiopathic Pulmonary Fibrosis
Questionnaire evaluation
Non Idiopathic Pulmonary Fibrosis
Questionnaire evaluation
Sarciodosis
Questionnaire evaluation
Healthy Controls
Questionnaire evaluation
Eligibility Criteria
Secondary Care
You may qualify if:
- Male or female
- Age greater than 18 years of age
- Any smoking status
- Diagnosis of Interstitial Lung Disease as defined below
- Full pulmonary lung function tests and routine immunological tests undertaken within 6 months of entry into study
You may not qualify if:
- Unable to give consent to take part
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Norfolk and Norwich Univeristy Hospital NHS foundation Trust
Norwich, Norfolk, NR47UY, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andrew M Wilson
University of East Anglia
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 9, 2012
First Posted
October 22, 2012
Study Start
November 1, 2012
Primary Completion
November 1, 2013
Study Completion
November 1, 2013
Last Updated
October 22, 2012
Record last verified: 2012-10